Short sleep duration and health outcomes: a systematic review, meta-analysis, and meta-regression

• Published in: Sleep medicine Vol. 32; pp. 246 - 256
• Main Authors: Itani, Osamu, Jike, Maki, Watanabe, Norio, Kaneita, Yoshitaka
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.04.2017
• Subjects: Cardiovascular Diseases - epidemiology; Diabetes mellitus; Humans; Hypertension; Meta-regression; Mortality; Neurology; Obesity - epidemiology; Sleep; Sleep deprivation; Sleep Medicine; Vascular disease; Hypertension; RR; OR; Diabetes mellitus; Mortality; CI; preferred reporting items for systematic reviews and meta-analyses; meta-analysis of observational studies in epidemiology; PRISMA; HR; odds ratio; Newcastle–Ottawa scale; risk ratio; Sleep deprivation; Meta-regression; Vascular disease; CER; control event rate; NOS; hazard ratio; confidence interval; MOOSE
• ISSN: 1389-9457; 1878-5506
• DOI: 10.1016/j.sleep.2016.08.006

Abstract Objective The dose–response of short sleep duration in mortality has been studied, in addition to the incidences of notable health complications and diseases such as diabetes mellitus, hypertension, cardiovascular diseases, stroke, coronary heart diseases, obesity, depression, and dyslipidemia. Methods We collected data from prospective cohort studies with follow-ups of one year or more on associations between short sleep duration and the outcomes. For the independent variable, we divided participants at baseline into short sleepers and normal sleepers. The primary outcomes were defined as mortality and an incident of each health outcome in the long-term follow-up. Risk ratios (RRs) for each outcome were calculated through meta-analyses of adjusted data from individual studies. Sub-group and meta-regression analyses were performed to investigate the association between each outcome and the duration of short sleep. Results Data from a cumulative total of 5,172,710 participants were collected from 153 studies. Short sleep was significantly associated with the mortality outcome (RR, 1.12; 95% CI, 1.08–1.16). Similar significant results were observed in diabetes mellitus (1.37, 1.22–1.53), hypertension (1.17, 1.09–1.26), cardiovascular diseases (1.16, 1.10–1.23), coronary heart diseases (1.26, 1.15–1.38), and obesity (1.38, 1.25–1.53). There was no sufficient usable evidence for meta-analyses in depression and dyslipidemia. Meta-regression analyses found a linear association between a statistically significant increase in mortality and sleep duration at less than six hours. No dose–response was identified in the other outcomes. Conclusions Based on our findings, future studies should examine the effectiveness of psychosocial interventions to improve sleep on reducing these health outcomes in general community settings.